IL-27 Induces an IFN-like Signature in Murine Macrophages Which in Turn Modulate Colonic Epithelium

Caroline Andrews,Mairi H. McLean,Julie A. Hixon,Sergio M. Pontejo,Tregei Starr,Courtney Malo,Margaret Cam,Lisa Ridnour,Heather Hickman,Olivia Steele-Mortimer,David A. Wink,Howard A. Young,Daniel W. McVicar,Wenqing Li,Scott K. Durum
DOI: https://doi.org/10.3389/fimmu.2023.1021824
IF: 7.3
2023-01-01
Frontiers in Immunology
Abstract:Mucosal delivery of IL-27 has been shown to have a therapeutic benefit in murine models of inflammatory bowel disease (IBD). The IL-27 effect was associated with phosphorylated STAT1 (pSTAT1), a product of IL27 receptor signaling, in bowel tissue. To determine whether IL-27 acted directly on colonic epithelium, murine colonoids and primary intact colonic crypts were shown to be unresponsive to IL-27 in vitro and to lack detectable IL-27 receptors. On the other hand, macrophages, which are present in inflamed colon tissue, were responsive to IL-27 in vitro. IL-27 induced pSTAT1 in macrophages, the transcriptome indicated an IFN-like signature, and supernatants induced pSTAT1 in colonoids. IL-27 induced anti-viral activity in macrophages and MHC Class II induction. We conclude that the effects of mucosal delivery of IL-27 in murine IBD are in part based on the known effects of IL27 inducing immunosuppression of T cells mediated by IL-10. We also conclude that IL-27 has potent effects on macrophages in inflamed colon tissue, generating mediators that in turn act on colonic epithelium.
What problem does this paper attempt to address?